Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-19

Clinical Trial Update: Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine [NA]

View source ↗

Summary

This update describes a completed clinical trial assessing whether combining orlistat with sibutramine provides additional weight loss in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orlistat (orlistat)
  • Sibutramine (sibutramine)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Obesity | NA | Status: COMPLETED